Contents
- 1 What is a paid drug addiction clinical trial?
- 2 What kinds of paid substance use studies are there?
- 3 What are the advantages of participating in paid drug addiction clinical trials?
- 4 What are the disadvantages of participating in paid drug addiction trials?
- 5 How do paid addiction trials work?
- 6 What do researchers learn from conducting paid drug addiction clinical trials?
- 7 Commonly Asked Questions (FAQs)
- 7.1 How much do paid drug addiction clinical trials pay?
- 7.2 How do I find out if I am eligible for a paid drug addiction clinical trial?
- 7.3 Can I leave a paid drug addiction clinical trial before it ends?
- 7.4 What information is collected in drug addiction clinical trials?
- 7.5 How long do paid drug addiction clinical trials last?
- 7.6 What questions should I ask before enrolling?
What is a paid drug addiction clinical trial?
Paid drug addiction trials are clinical studies that focus on understanding the biological nature of advanced substance abuse and viable drug candidates that may assist drug cessation. In many cases, patients who are heavily involved in substance abuse have tried a myriad of treatments to help them quit. Additionally, scientists conclude addiction may be partly hereditary in nature.
Therefore, researchers conduct paid drug addiction trials to test out treatments to aid withdrawal and to curb cravings. They also sometimes pair behavioral modification treatments in conjunction with drug therapies so there is much to be discovered in this arena. Participants are compensated for their time, travel, and the demands of the study schedule.
Quick Facts: Paid Drug Addiction Clinical Trials
- Actively recruiting US studies (July 2026): 501 for substance use disorder, 221 for opioid use disorder, 179 for alcohol use disorder, and 111 for smoking cessation (ClinicalTrials.gov)
- Typical compensation: $50–$100 per completed visit for outpatient Phase 2–4 studies; inpatient Phase 1 studies pay substantially more
- Cost to participate: $0 — study-related treatment and visits are paid for by the sponsor
- Who runs them: Academic medical centers and research sites, many funded through the NIDA Clinical Trials Network
- Find one near you: Browse paid clinical trials by state
2026 Drug Addiction Research Updates
- Treatment gap drives recruitment: SAMHSA’s 2024 National Survey on Drug Use and Health found 48.4 million Americans had a past-year substance use disorder and 80% of those needing treatment didn’t get it — a major reason treatment trials continue expanding.
- Fentanyl vaccines reach human trials: The first anti-fentanyl vaccine candidates are entering Phase 1 trials in 2026, developed at institutions including Boston Children’s Hospital and the University of Montana.
- Longer-acting medications: Studies of extended-release treatments, including a one-year implantable naltrexone device, are recruiting participants with opioid use disorder.
- More than 500 substance use studies are recruiting across the US as of July 2026, per ClinicalTrials.gov.
How do I find paid drug addiction clinical trials near me?
There are several avenues to finding a paid clinical trial specifically targeting substance abuse in your local area. We suggest you start by communicating interest with your personal physician. He or she may be able to assist in finding a study appropriate for your specific needs. Other ways of finding paid clinical trials near you can be found on most government websites and some research-based institutions. It may be worthwhile to also visit your local drug abuse treatment center for more information clinical trials in your area.
Who conducts clinical trials relating to substance abuse?
Most substance use clinical trials in the United States are run by academic medical centers and hospital research programs, many funded by the National Institute on Drug Abuse (NIDA) Clinical Trials Network. Pharmaceutical companies also sponsor trials of new medications for opioid, alcohol, and stimulant use disorders. As of July 2026, more than 500 substance use disorder studies are actively recruiting participants across the country, according to ClinicalTrials.gov.
What kinds of paid substance use studies are there?
Paid drug addiction research is broader than medication trials. Depending on the study type, you may qualify whether you are seeking treatment, already in recovery, or not planning to quit at all. Here are the main categories and what they typically pay:
| Study type | Typical pay | What is involved |
|---|---|---|
| Medication trials (opioid, alcohol, stimulant use) | $50–$100 per visit | 8–24 weeks of outpatient visits with lab work |
| Behavioral treatment studies | $25–$75 per visit, plus incentives for verified abstinence | Counseling or app-based programs with regular check-ins |
| Brain imaging and human laboratory studies | $100–$300 per session | A few long visits with MRI or other scans; many recruit people who currently use drugs, and some also enroll healthy volunteers as a comparison group |
| Residential research stays | Higher total pay, set per protocol | Days to weeks living at a research unit under medical supervision |
| Remote and survey studies | $10–$50 per task | Questionnaires or app check-ins from home |
Every study sets its own compensation. The exact amounts and payment schedule appear in the consent form before you enroll.
Can I join a study if I’m still using?
Sometimes, yes. Treatment trials usually require that you want to start treatment, but many imaging and human laboratory studies specifically recruit people who currently use drugs and are not seeking treatment. Researchers need to understand how substances affect the brain and body, and that research depends on volunteers who are still using. Be honest during screening. Eligibility rules differ with every protocol, and misreporting your use can put your safety at risk.
What happens if I relapse during a study?
In most treatment studies, relapse does not automatically end your participation. Researchers expect it, because relapse is part of the condition they are studying, and many protocols are designed to keep following participants through it. Ask the study coordinator up front how a positive drug screen is handled, what happens to your compensation, and whether you can continue in the study.
Beyond trials: state programs that pay for recovery
Clinical trials are not the only legitimate way to be paid in recovery. Five states (California, Delaware, Hawaii, Montana, and Washington) now run Medicaid contingency management programs, which pay members in gift-card incentives for verified abstinence from stimulants. Depending on the state, eligible members can earn $596 to $1,092 over 12 to 24 weeks. California’s Recovery Incentives Program is the largest. If you live in one of these states and stimulant use is the concern, ask a Medicaid-enrolled treatment provider about enrolling.
What are the advantages of participating in paid drug addiction clinical trials?
Participating in a paid substance use clinical trial can give you access to specialized treatment and care. The key advantage is that you would not have any associated out of pocket costs for receiving high-value care and treatment. Rehabilitation centers specializing in drug addiction can cost thousands of dollars, putting it out of reach for many. You may meet others who share similar afflictions, and your participation may facilitate access to support groups and resources.
What are the disadvantages of participating in paid drug addiction trials?
Participating in a paid addiction trial may present some personal discomfort both emotionally and physically. The process of receiving treatment may also present you with some measurable inconvenience with respect to attending check-ins for vital signs, mandatory therapies, and testing, and the like. Moreso, the intervention therapy may not work as intended.
How do paid addiction trials work?
Paid addiction clinical trials are part of a more aggressive campaign towards Harm Reduction efforts. To help in the recovery process, paid initiatives such as contingency management, and paid clinical trials contribute towards overall wellness and sobriety. The eligibility criteria may vary depending upon the clinical sponsor, but the process of participation may involve medication adherence, and behavioral modification therapy to receive full payment.
Substance use trials move through the same four FDA-regulated phases as any other study: Phase I establishes safety and dosing (usually with healthy volunteers, and typically the highest paying), Phases II and III test how well the treatment works in progressively larger groups, and Phase IV monitors long-term safety after approval. Our guide to the types of paid clinical trials explains each phase and what to expect as a participant.
What do researchers learn from conducting paid drug addiction clinical trials?
Researchers learn a great deal from conducting paid drug addiction clinical trials. According to the 2024 National Survey on Drug Use and Health, 48.4 million Americans aged 12 and older — 16.8% — had a substance use disorder in the past year.
Substance use disorders frequently occur alongside other health conditions. Many people in treatment studies also manage mental health conditions such as depression, anxiety, or PTSD, which is why many trials study both together.
Researchers seek more effective treatment options that help with withdrawal, desire, and post-addiction needs. The hope is that paid volunteers continue to enroll in these programs so that we can find viable solutions to help on a national scale.
Drug addiction statistics at a glance (Source: SAMHSA, 2024 National Survey on Drug Use and Health):
- 48.4 million Americans aged 12 and older (16.8%) had a substance use disorder in the past year.
- 9.7% had an alcohol use disorder, and 9.8% had a drug use disorder.
- About 4.8 million people had an opioid use disorder.
- 80% of people who needed substance use treatment did not receive it — one reason so many studies are actively recruiting volunteers.
Commonly Asked Questions (FAQs)
-
How much do paid drug addiction clinical trials pay?
Most outpatient substance use studies pay $50–$100 per completed visit, plus travel reimbursement. Screening visits often pay less, while inpatient Phase 1 studies can pay several thousand dollars in total. Compensation depends on the length of the study, the number of visits, and the procedures involved. Payment is typically prorated, so you are paid for the visits you complete even if you leave early. Studies with overnight stays tend to be among the highest paid clinical trials.
-
How do I find out if I am eligible for a paid drug addiction clinical trial?
Each study lists eligibility criteria covering age, the substance involved, how long you have used it, other health conditions, current medications, and location. The first step is usually a short phone screening with the study coordinator, followed by an in-person screening visit with lab work. Being turned down for one study does not rule you out of others — criteria differ widely between trials.
-
Can I leave a paid drug addiction clinical trial before it ends?
Yes. Participation is voluntary and you can withdraw at any time, for any reason. If the study involves medication, talk with the study team before stopping so they can help you discontinue safely. Compensation is typically prorated, so you keep payment for the visits you completed.
-
What information is collected in drug addiction clinical trials?
Expect to share your substance use history, medical and mental health history, and current medications, along with routine urine and blood tests and vital signs during the study. Many federally funded addiction studies are covered by an NIH Certificate of Confidentiality, which protects your identifiable information from being released, even under subpoena.
-
How long do paid drug addiction clinical trials last?
Most outpatient medication studies run 8–24 weeks, with follow-up visits afterward. Some Phase 1 studies involve short inpatient stays, while long-term follow-up studies can continue for a year or more. The consent form spells out the full schedule before you enroll.
-
What questions should I ask before enrolling?
Before you sign the consent form, ask: What is the study testing, and could I receive a placebo? What side effects are expected? How much is the compensation, and when is it paid? What happens if I need to leave early? Is travel reimbursed? What care is available if something goes wrong? The FDA explains your rights in its informed consent guide, and the study coordinator is required to answer all of these before you enroll.